Autologous Bone Marrow Derived Stem Cells for the Treatment of Multiple Sclerosis.
Condition(s):Multiple SclerosisLast Updated:March 17, 2020Recruiting
Hide Studies Not Open or Pending
Condition(s):Multiple SclerosisLast Updated:March 17, 2020Recruiting
Condition(s):Motor Neuron Disease; Amyotrophic Lateral Sclerosis; Primary Lateral Sclerosis; Progressive Muscular Atrophy; Progressive Bulbar PalsiesLast Updated:June 6, 2018Unknown status
Condition(s):RheumatoId Arthritis; Osteoarthritis, Knee; Osteoarthritis, HipLast Updated:March 17, 2020Active, not recruiting
Condition(s):Age Related Macular DegenerationLast Updated:December 24, 2013Unknown status
Condition(s):Dilated CardiomyopathyLast Updated:June 24, 2015Completed
Condition(s):Spinal Cord InjuryLast Updated:November 21, 2012Unknown status
Condition(s):Duchenne Muscular DystrophyLast Updated:March 17, 2020Recruiting
Condition(s):Type 2 Diabetes MellitusLast Updated:October 1, 2012Unknown status
Condition(s):Retinitis PigmentosaLast Updated:July 21, 2017Completed
Condition(s):Type 2 Diabetes MellitusLast Updated:October 21, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.